- Investor's Business Daily•11 months ago
The European Union's medical advisory committee endorsed several key drugs from leading stocks Friday, making EU approval likely for some potential blockbusters: • The Committee for Medicinal Products ...
- Investor's Business Daily•last year
Top-rated specialty drugmaker Horizon Pharma beat first-quarter sales estimates and settled a patent suit, but its stock fell 6% to 27.62 on Friday. Horizon's (HZNP) earnings excluding one-time items rose ...
NasdaqGS - NasdaqGS Delayed Price. Currency in USD
|Day's Range||0.00 - 0.00|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||N/A|
|Avg Vol (3m)||N/A|
|Dividend & Yield||N/A (N/A)|